ABEMACICLIB
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...- Breast cancer treatment successfully stops tumour growthMelbourne, July 28 (IANS) A breast cancer treatment developed by Australian researchers has successfully halted tumour growth for twice as ...
- Load More